Contents: Difference between revisions

From ACD Percepta
Jump to navigation Jump to search
No edit summary
No edit summary
Line 54: Line 54:
** [[Impurity Profiling]]
** [[Impurity Profiling]]
* [[Health Effects]]
* [[Health Effects]]
* [[hERG Inhibition]]
* Irritation
* Irritation
** [[Eye Irritation]]
** [[Eye Irritation]]
** [[Skin Irritation]]
** [[Skin Irritation]]
* [[LogD]]
* [[LogP]]
* [[LogP]]
* [[MRDD]]
* Passive Absorption
* Passive Absorption
** [[Absorption]]
** [[Absorption]]
Line 65: Line 68:
** [[P-gp Inhibitors]]
** [[P-gp Inhibitors]]
** [[P-gp Substrates]]
** [[P-gp Substrates]]
* [[pKa]]
** [[pKa#ACD/pKa Classic|ACD/pKa Classic]]
** [[pKa#ACD/pKa GALAS|ACD/pKa GALAS]]
** [[ACD/pKa GALAS Tutorial]]
* [[PK Explorer]]
** [[PK Explorer Tutorial|Tutorial]]
* [[P450 Inhibitors]]
* [[P450 Inhibitors]]
* [[P450 Substrates]]
* [[P450 Substrates]]
Line 74: Line 83:
** [[CYP2D6 Regioselectivity]]
** [[CYP2D6 Regioselectivity]]
** [[CYP3A4 Regioselectivity]]
** [[CYP3A4 Regioselectivity]]
* [[Sigma]]
* [[Solubility in DMSO]]
* [[Solubility in DMSO]]
* [[PK Explorer]]
* [[MRDD]]
* [[hERG Inhibition]]
* [[Sigma]]
* [[LogD]]
* Water Solubility
* Water Solubility
** [[LogS]]
** [[LogS]]
** [[ACD/LogSw GALAS|LogSw]]
** [[ACD/LogSw GALAS|LogSw]]
** [[ACD/Qualitative Solubility GALAS|Qualitative Solubility]]
** [[ACD/Qualitative Solubility GALAS|Qualitative Solubility]]
* [[pKa]]
 
<br />
<br />



Revision as of 08:12, 2 October 2012